| Literature DB >> 30860443 |
Sander B Kant1, Carlo Colla1, Eric van den Kerckhove1,2,3, Andrzej Piatkowski de Grzymala1.
Abstract
BACKGROUND: Severe facial hypertrophic scars are known to severely impact emotional well-being. Pressure therapy by means of transparent face masks has been used for almost 40 years, but evidence about the clinical effects remains sparse.Entities:
Keywords: Orthotics; face masks; facial scars; pressure therapy
Mesh:
Year: 2019 PMID: 30860443 PMCID: PMC6557006 DOI: 10.1177/0309364619836023
Source DB: PubMed Journal: Prosthet Orthot Int ISSN: 0309-3646 Impact factor: 1.895
Figure 1.PRISMA 2009 flow diagram.
Study characteristics.
| References | Study design | Study population | Technical details | Therapy details | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Lead author name | Number of patients | Age | Nationality | Scar type | Mask materials | Fabrication method | Wearing | Pressure | Timing | |
| Kant et al.[ | Case series | 21 | 34–80 | Dutch patients | Protruding skin flaps and hypertrophic scars after facial flap surgery | Transparent polycarbonate material with a silicone inner liner | Conventional positive and negative molding | 10–12 hours of daily wearing | Targeted pressure was 20 mmHg, not objectified in this study | Therapy started between 1 and 3 months after surgery took place |
| Wei et al.[ | Case series | 2 | 1 and 6 years | Chinese patients | Hypertrophic facial burn scars | Biocompatible and transparent 3D printing material with a double silicone inner liner | 3D scanning and printing | 20 hours of daily wearing | Average pressure was 11.3 mmHg in one of the two patients measured. The type of measurement device is not described | It is not mentioned when therapy commenced |
| Wei et al.[ | Cohort study | 10 | 14–50 | Chinese patients | Hypertrophic facial burn scars | Biocompatible and transparent 3D printing material with a silicone inner liner | 3D scanning and printing | 20 hours of daily wearing | Average pressure was 13.32 mmHg | Therapy started between 21 days and 6 months after injury |
| References | Outcome measures | Follow-up period | Control group | Main results | Summarized clinical effects | Adverse effects | Level of evidence | |||
| Kant et al.[ | POSAS scores | 46 weeks, range: 11–112 | Absent | Components of the Patient, Observer and Total POSAS score decreased significantly. The mean Total POSAS score decreased from 48.87 (SD: 14.93) to 30.13 (SD: 9.82) ( | Significant improvement in Total POSAS and Patient Score of the POSAS. Also, significant improvement in scar thickness, pliability, and surface area in both the Patient and Observer Scales of the POSAS. In addition, significant improvement in scar itchiness and pigmentation in the Patient Scale | None reported | Level 4 | |||
| Wei et al.[ | Scar thickness, measured by ultrasound | 3 months | Absent | Non-significant decrease in average scar thickness in both patients after 1 month and after 3 months compared to pre-treatment. No P-values were presented | No significant scar improvement | Problems with scar flattening around the mouth | Level 4 | |||
| Wei et al.[ | Scar thickness, measured by ultrasound, scar hardness by means of a durometer and POSAS scores | 1 month | 5 patients were immediately treated and 5 patients were treated 1 month later | Significant decrease in scar thickness at the forehead, eyes, nose, and mouth in both groups ( | Significant improvement in scar thickness and hardness measured by ultrasound and durometer. Also, significant improvement in the overall scar score of the Patient Scale and in the Observer scale of the POSAS. Furthermore, significant improvement in the Total Score of the Observer Scale | None reported | Level 4 | |||